Is Willow legit?
Yes, Willow is a real, operating telehealth company, and it is not a scam. But its two third-party records disagree, which is worth understanding before you hand over a card. It holds 3.7 out of 5 across 294 Trustpilot reviews, while its BBB profile reads D- (not accredited), a gap that almost always means billing and cancellation disputes rather than the medicine. On our own methodology it scores 7.5/10, at $299/mo.
This page is written by GLP-1 Picks, not by Willow. Willow pays us nothing, and every Willow link on this page goes to our own review rather than to them. Some other providers we cover do pay us a commission. Every provider is scored by the same published methodology.
Who actually operates it
Austin, TX
What third-party reviewers say
Willow (startwillow.com) has a polarized Trustpilot footprint: a TrustScore around 3.7/5 with roughly 56% five-star and 34% one-star reviews. Fans praise fast doctor responses and simple flat-rate pricing, but recurring criticism centers on shipping delays, orders arriving without medication, difficulty getting refunds, and generic/AI-feeling support replies. It is NOT BBB accredited and carries a low D- BBB grade (5 complaints, including one unanswered), plus third-party reporting that some marketing testimonials were fabricated.
Reddit sentiment (mixed): Real weight-loss results reported (12 lbs in 7 weeks, 29 lbs in 5 months) alongside complaints of shipping delays, unresponsive support, and a notable concern that some Willow ad testimonials (e.g. 'Jenna Walsh') were fabricated/AI-generated influencers.
Trustpilot verified June 19, 2026, external-reviews verification pass..
What people complain about with Willow
- •Compounded-only, no brand-name Wegovy or Zepbound through the platform
- •Tirzepatide pricing reaches $499-$524 at higher doses, starting dose is $399/mo
- •Cash-pay only, no insurance billing, though they provide superbills for FSA/HSA
- •Founded in 2024, less track record than Ro or Hims, though growth has been fast
Our verdict
Willow is a solid mid-tier compounded-only GLP-1 platform. At $299/mo compounded semaglutide (injectable or daily oral) and $399/mo compounded tirzepatide, pricing is above ultra-cheap options like Lemonaid Health but reflects real clinical oversight. The oral semaglutide daily tablet is a genuine differentiator for needle-averse users. Best for cash-pay patients who want compounded-only with ongoing provider support.
Willow, $299/mo, scored 7.5/10 on our methodology.
Informational only, not medical advice. Ratings and prices verified at the dates shown and change frequently; confirm on Willow's own site before purchasing.